Stereotactic Body Radiotherapy for Prostate Cancer: Where, When, and Who? A Bibliometric Analysis

CONCLUSION: The number of publications and citations on SBRT for prostate cancer has grown linearly in the last decades. The United States is the leading country in this research field, and the use of SBRT in oligometastatic disease, reirradiation, and salvage seems to be hot topics in this research field.PMID:34618725 | DOI:10.1097/COC.0000000000000869
Source: Clinical Prostate Cancer - Category: Cancer & Oncology Authors: Source Type: research